Context Therapeutics Inc. (CNTX)
NASDAQ·Healthcare·Biotechnology
$1.45
+1.76%
Mkt Cap $160.79M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$5.25
Range $4.50 – $6.00
Implied Upside
+263.3%
Consensus $5.25 vs current $1.45
NASDAQ·Healthcare·Biotechnology
$1.45
+1.76%
Mkt Cap $160.79M
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$5.25
Range $4.50 – $6.00
+263.3%
Consensus $5.25 vs current $1.45